nodes	percent_of_prediction	percent_of_DWPC	metapath
Loperamide—ABCB1—Glyburide—gestational diabetes	0.151	0.625	CbGbCtD
Loperamide—CYP3A4—Glyburide—gestational diabetes	0.0902	0.375	CbGbCtD
Loperamide—CACNA1A—islet of Langerhans—gestational diabetes	0.0357	0.12	CbGeAlD
Loperamide—POMC—adipose tissue—gestational diabetes	0.0239	0.08	CbGeAlD
Loperamide—POMC—vagina—gestational diabetes	0.0198	0.0665	CbGeAlD
Loperamide—POMC—head—gestational diabetes	0.0183	0.0614	CbGeAlD
Loperamide—CACNA1A—head—gestational diabetes	0.0175	0.0587	CbGeAlD
Loperamide—CALM3—islet of Langerhans—gestational diabetes	0.013	0.0436	CbGeAlD
Loperamide—CALM2—islet of Langerhans—gestational diabetes	0.0102	0.0343	CbGeAlD
Loperamide—CALM1—islet of Langerhans—gestational diabetes	0.0102	0.0341	CbGeAlD
Loperamide—OPRD1—head—gestational diabetes	0.0101	0.0339	CbGeAlD
Loperamide—CALM2—embryo—gestational diabetes	0.00989	0.0331	CbGeAlD
Loperamide—CALM1—embryo—gestational diabetes	0.00984	0.033	CbGeAlD
Loperamide—OPRK1—head—gestational diabetes	0.0097	0.0325	CbGeAlD
Loperamide—CALM3—uterus—gestational diabetes	0.00849	0.0285	CbGeAlD
Loperamide—CALM3—adipose tissue—gestational diabetes	0.0083	0.0278	CbGeAlD
Loperamide—Levomethadyl Acetate—CYP19A1—gestational diabetes	0.0079	0.315	CrCbGaD
Loperamide—Clotrimazole—CYP19A1—gestational diabetes	0.0079	0.315	CrCbGaD
Loperamide—CALM3—vagina—gestational diabetes	0.0069	0.0231	CbGeAlD
Loperamide—OPRM1—head—gestational diabetes	0.0069	0.0231	CbGeAlD
Loperamide—CALM2—uterus—gestational diabetes	0.00667	0.0223	CbGeAlD
Loperamide—CALM1—uterus—gestational diabetes	0.00664	0.0222	CbGeAlD
Loperamide—CALM2—adipose tissue—gestational diabetes	0.00652	0.0219	CbGeAlD
Loperamide—CALM1—adipose tissue—gestational diabetes	0.00649	0.0218	CbGeAlD
Loperamide—CALM2—vagina—gestational diabetes	0.00542	0.0182	CbGeAlD
Loperamide—CALM1—vagina—gestational diabetes	0.0054	0.0181	CbGeAlD
Loperamide—CALM2—head—gestational diabetes	0.00501	0.0168	CbGeAlD
Loperamide—CALM1—head—gestational diabetes	0.00498	0.0167	CbGeAlD
Loperamide—Tamoxifen—CYP19A1—gestational diabetes	0.00467	0.186	CrCbGaD
Loperamide—Methadone—CYP19A1—gestational diabetes	0.00463	0.185	CrCbGaD
Loperamide—CYP2C8—vagina—gestational diabetes	0.00449	0.0151	CbGeAlD
Loperamide—ABCB1—islet of Langerhans—gestational diabetes	0.00406	0.0136	CbGeAlD
Loperamide—CYP2B6—vagina—gestational diabetes	0.00403	0.0135	CbGeAlD
Loperamide—ABCB1—embryo—gestational diabetes	0.00393	0.0132	CbGeAlD
Loperamide—CYP2B6—head—gestational diabetes	0.00372	0.0125	CbGeAlD
Loperamide—CYP2B6—Biological oxidations—GGCT—gestational diabetes	0.00352	0.00809	CbGpPWpGaD
Loperamide—OPRK1—Mecp2 and Associated Rett Syndrome—FGF2—gestational diabetes	0.00337	0.00772	CbGpPWpGaD
Loperamide—POMC—Metabolism—GGCT—gestational diabetes	0.00322	0.00739	CbGpPWpGaD
Loperamide—OPRD1—G alpha (i) signalling events—MTNR1B—gestational diabetes	0.00319	0.00732	CbGpPWpGaD
Loperamide—CYP2C8—Biological oxidations—GGCT—gestational diabetes	0.00298	0.00685	CbGpPWpGaD
Loperamide—OPRD1—GPCRs, Class A Rhodopsin-like—MTNR1B—gestational diabetes	0.00296	0.0068	CbGpPWpGaD
Loperamide—CALM3—Diseases associated with visual transduction—RBP4—gestational diabetes	0.00294	0.00676	CbGpPWpGaD
Loperamide—CALM1—Diseases associated with visual transduction—RBP4—gestational diabetes	0.00285	0.00654	CbGpPWpGaD
Loperamide—CALM2—Diseases associated with visual transduction—RBP4—gestational diabetes	0.00285	0.00654	CbGpPWpGaD
Loperamide—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.00285	0.00654	CbGpPWpGaD
Loperamide—POMC—Metabolism—GLS2—gestational diabetes	0.00282	0.00646	CbGpPWpGaD
Loperamide—CYP2B6—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.00281	0.00645	CbGpPWpGaD
Loperamide—OPRK1—G alpha (i) signalling events—MTNR1B—gestational diabetes	0.0028	0.00642	CbGpPWpGaD
Loperamide—CACNA1A—Metabolism—GGCT—gestational diabetes	0.00278	0.00639	CbGpPWpGaD
Loperamide—CYP2D6—head—gestational diabetes	0.00277	0.00927	CbGeAlD
Loperamide—POMC—GPCR downstream signaling—MTNR1B—gestational diabetes	0.00275	0.00631	CbGpPWpGaD
Loperamide—ABCB1—HIF-1-alpha transcription factor network—GCK—gestational diabetes	0.00266	0.00611	CbGpPWpGaD
Loperamide—CALM3—Transmission across Chemical Synapses—GLS2—gestational diabetes	0.00266	0.0061	CbGpPWpGaD
Loperamide—ABCB1—uterus—gestational diabetes	0.00265	0.00888	CbGeAlD
Loperamide—OPRK1—GPCRs, Class A Rhodopsin-like—MTNR1B—gestational diabetes	0.0026	0.00596	CbGpPWpGaD
Loperamide—ABCB1—adipose tissue—gestational diabetes	0.00259	0.00868	CbGeAlD
Loperamide—CALM1—Transmission across Chemical Synapses—GLS2—gestational diabetes	0.00257	0.0059	CbGpPWpGaD
Loperamide—CALM2—Transmission across Chemical Synapses—GLS2—gestational diabetes	0.00257	0.0059	CbGpPWpGaD
Loperamide—OPRD1—Class A/1 (Rhodopsin-like receptors)—MTNR1B—gestational diabetes	0.00254	0.00582	CbGpPWpGaD
Loperamide—POMC—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	0.00252	0.00578	CbGpPWpGaD
Loperamide—POMC—Signaling by GPCR—MTNR1B—gestational diabetes	0.0025	0.00573	CbGpPWpGaD
Loperamide—CYP2D6—Biological oxidations—GGCT—gestational diabetes	0.00245	0.00562	CbGpPWpGaD
Loperamide—CACNA1A—Metabolism—GLS2—gestational diabetes	0.00243	0.00559	CbGpPWpGaD
Loperamide—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.00241	0.00553	CbGpPWpGaD
Loperamide—CYP2C8—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.00238	0.00546	CbGpPWpGaD
Loperamide—OPRM1—G alpha (i) signalling events—MTNR1B—gestational diabetes	0.00236	0.00543	CbGpPWpGaD
Loperamide—CYP2B6—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.00231	0.0053	CbGpPWpGaD
Loperamide—OPRK1—Class A/1 (Rhodopsin-like receptors)—MTNR1B—gestational diabetes	0.00222	0.00511	CbGpPWpGaD
Loperamide—OPRM1—GPCRs, Class A Rhodopsin-like—MTNR1B—gestational diabetes	0.00219	0.00504	CbGpPWpGaD
Loperamide—ABCB1—vagina—gestational diabetes	0.00215	0.00722	CbGeAlD
Loperamide—CALM3—Neuronal System—GLS2—gestational diabetes	0.00204	0.00467	CbGpPWpGaD
Loperamide—CALM3—Cellular roles of Anthrax toxin—TNF—gestational diabetes	0.002	0.00459	CbGpPWpGaD
Loperamide—ABCB1—head—gestational diabetes	0.00199	0.00667	CbGeAlD
Loperamide—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.00198	0.00454	CbGpPWpGaD
Loperamide—CALM2—Neuronal System—GLS2—gestational diabetes	0.00197	0.00452	CbGpPWpGaD
Loperamide—CALM1—Neuronal System—GLS2—gestational diabetes	0.00197	0.00452	CbGpPWpGaD
Loperamide—CYP2C8—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.00195	0.00449	CbGpPWpGaD
Loperamide—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.00195	0.00448	CbGpPWpGaD
Loperamide—CALM2—Cellular roles of Anthrax toxin—TNF—gestational diabetes	0.00194	0.00444	CbGpPWpGaD
Loperamide—CALM1—Cellular roles of Anthrax toxin—TNF—gestational diabetes	0.00194	0.00444	CbGpPWpGaD
Loperamide—OPRD1—GPCR ligand binding—MTNR1B—gestational diabetes	0.00193	0.00443	CbGpPWpGaD
Loperamide—OPRM1—Class A/1 (Rhodopsin-like receptors)—MTNR1B—gestational diabetes	0.00188	0.00432	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—LEPR—gestational diabetes	0.00187	0.00429	CbGpPWpGaD
Loperamide—OPRK1—GPCR ligand binding—MTNR1B—gestational diabetes	0.00169	0.00389	CbGpPWpGaD
Loperamide—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.0016	0.00368	CbGpPWpGaD
Loperamide—CYP3A4—Biological oxidations—GGCT—gestational diabetes	0.0016	0.00368	CbGpPWpGaD
Loperamide—CYP3A4—Tryptophan metabolism—CYP19A1—gestational diabetes	0.0016	0.00367	CbGpPWpGaD
Loperamide—CALM3—Phospholipase C-mediated cascade—FGF2—gestational diabetes	0.00156	0.00357	CbGpPWpGaD
Loperamide—POMC—Metabolism—NAMPT—gestational diabetes	0.00154	0.00354	CbGpPWpGaD
Loperamide—POMC—Metabolism—GCK—gestational diabetes	0.00153	0.00352	CbGpPWpGaD
Loperamide—CALM2—Cardiac Hypertrophic Response—FGF2—gestational diabetes	0.00153	0.00351	CbGpPWpGaD
Loperamide—CALM1—Cardiac Hypertrophic Response—FGF2—gestational diabetes	0.00153	0.00351	CbGpPWpGaD
Loperamide—POMC—Metabolism of proteins—LEP—gestational diabetes	0.00152	0.00349	CbGpPWpGaD
Loperamide—CALM1—Phospholipase C-mediated cascade—FGF2—gestational diabetes	0.00151	0.00346	CbGpPWpGaD
Loperamide—CALM2—Phospholipase C-mediated cascade—FGF2—gestational diabetes	0.00151	0.00346	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—MTNR1B—gestational diabetes	0.00148	0.00339	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—RBP4—gestational diabetes	0.00144	0.0033	CbGpPWpGaD
Loperamide—OPRM1—GPCR ligand binding—MTNR1B—gestational diabetes	0.00143	0.00329	CbGpPWpGaD
Loperamide—ABCB1—HIF-1-alpha transcription factor network—LEP—gestational diabetes	0.00136	0.00312	CbGpPWpGaD
Loperamide—CALM2—Endochondral Ossification—FGF2—gestational diabetes	0.00135	0.00311	CbGpPWpGaD
Loperamide—CALM1—Endochondral Ossification—FGF2—gestational diabetes	0.00135	0.00311	CbGpPWpGaD
Loperamide—CACNA1A—Metabolism—NAMPT—gestational diabetes	0.00133	0.00306	CbGpPWpGaD
Loperamide—CACNA1A—Metabolism—GCK—gestational diabetes	0.00133	0.00304	CbGpPWpGaD
Loperamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.00129	0.00297	CbGpPWpGaD
Loperamide—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.00128	0.00293	CbGpPWpGaD
Loperamide—CYP2B6—Biological oxidations—CYP19A1—gestational diabetes	0.00123	0.00281	CbGpPWpGaD
Loperamide—CYP2B6—Metapathway biotransformation—CYP19A1—gestational diabetes	0.00121	0.00278	CbGpPWpGaD
Loperamide—CALM3—Carbohydrate metabolism—GCK—gestational diabetes	0.00118	0.0027	CbGpPWpGaD
Loperamide—CALM2—Carbohydrate metabolism—GCK—gestational diabetes	0.00114	0.00261	CbGpPWpGaD
Loperamide—CALM1—Carbohydrate metabolism—GCK—gestational diabetes	0.00114	0.00261	CbGpPWpGaD
Loperamide—POMC—Metabolism—CYP19A1—gestational diabetes	0.00112	0.00257	CbGpPWpGaD
Loperamide—OPRD1—GPCR downstream signaling—MTNR1B—gestational diabetes	0.00109	0.00251	CbGpPWpGaD
Loperamide—CALM2—MicroRNAs in cardiomyocyte hypertrophy—FGF2—gestational diabetes	0.00109	0.0025	CbGpPWpGaD
Loperamide—CALM1—MicroRNAs in cardiomyocyte hypertrophy—FGF2—gestational diabetes	0.00109	0.0025	CbGpPWpGaD
Loperamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.00105	0.00241	CbGpPWpGaD
Loperamide—CYP2C8—Biological oxidations—CYP19A1—gestational diabetes	0.00104	0.00238	CbGpPWpGaD
Loperamide—CALM3—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—gestational diabetes	0.00104	0.00238	CbGpPWpGaD
Loperamide—CYP2C8—Metapathway biotransformation—CYP19A1—gestational diabetes	0.00102	0.00235	CbGpPWpGaD
Loperamide—CALM1—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—gestational diabetes	0.001	0.0023	CbGpPWpGaD
Loperamide—CALM2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—gestational diabetes	0.001	0.0023	CbGpPWpGaD
Loperamide—OPRD1—Signaling by GPCR—MTNR1B—gestational diabetes	0.000991	0.00228	CbGpPWpGaD
Loperamide—CACNA1A—Metabolism—CYP19A1—gestational diabetes	0.000969	0.00222	CbGpPWpGaD
Loperamide—OPRK1—GPCR downstream signaling—MTNR1B—gestational diabetes	0.000957	0.0022	CbGpPWpGaD
Loperamide—CALM1—Cardiac Hypertrophic Response—TNF—gestational diabetes	0.00093	0.00213	CbGpPWpGaD
Loperamide—CALM2—Cardiac Hypertrophic Response—TNF—gestational diabetes	0.00093	0.00213	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—MTNR1B—gestational diabetes	0.000869	0.002	CbGpPWpGaD
Loperamide—CYP2D6—Biological oxidations—CYP19A1—gestational diabetes	0.000852	0.00196	CbGpPWpGaD
Loperamide—CYP2D6—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000841	0.00193	CbGpPWpGaD
Loperamide—CALM3—Downstream signaling in naïve CD8+ T cells—TNF—gestational diabetes	0.000831	0.00191	CbGpPWpGaD
Loperamide—OPRM1—GPCR downstream signaling—MTNR1B—gestational diabetes	0.000809	0.00186	CbGpPWpGaD
Loperamide—ABCB1—Integrated Pancreatic Cancer Pathway—AR—gestational diabetes	0.000809	0.00186	CbGpPWpGaD
Loperamide—CALM2—Downstream signaling in naïve CD8+ T cells—TNF—gestational diabetes	0.000804	0.00184	CbGpPWpGaD
Loperamide—CALM1—Downstream signaling in naïve CD8+ T cells—TNF—gestational diabetes	0.000804	0.00184	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—LEPR—gestational diabetes	0.000741	0.0017	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—MTNR1B—gestational diabetes	0.000735	0.00169	CbGpPWpGaD
Loperamide—CALM3—Alzheimers Disease—TNF—gestational diabetes	0.00072	0.00165	CbGpPWpGaD
Loperamide—CALM3—Downstream signaling of activated FGFR—FGF2—gestational diabetes	0.000711	0.00163	CbGpPWpGaD
Loperamide—CALM2—Alzheimers Disease—TNF—gestational diabetes	0.000696	0.0016	CbGpPWpGaD
Loperamide—CALM1—Alzheimers Disease—TNF—gestational diabetes	0.000696	0.0016	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—MBL2—gestational diabetes	0.00069	0.00158	CbGpPWpGaD
Loperamide—CALM2—Downstream signaling of activated FGFR—FGF2—gestational diabetes	0.000688	0.00158	CbGpPWpGaD
Loperamide—CALM1—Downstream signaling of activated FGFR—FGF2—gestational diabetes	0.000688	0.00158	CbGpPWpGaD
Loperamide—CALM3—Downstream signal transduction—FGF2—gestational diabetes	0.000669	0.00153	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—MBL2—gestational diabetes	0.000667	0.00153	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—MBL2—gestational diabetes	0.000667	0.00153	CbGpPWpGaD
Loperamide—CALM3—Signaling by FGFR—FGF2—gestational diabetes	0.000665	0.00153	CbGpPWpGaD
Loperamide—CALM2—MicroRNAs in cardiomyocyte hypertrophy—TNF—gestational diabetes	0.000663	0.00152	CbGpPWpGaD
Loperamide—CALM1—MicroRNAs in cardiomyocyte hypertrophy—TNF—gestational diabetes	0.000663	0.00152	CbGpPWpGaD
Loperamide—CALM3—Signaling by ERBB2—FGF2—gestational diabetes	0.000662	0.00152	CbGpPWpGaD
Loperamide—CALM3—DAP12 signaling—FGF2—gestational diabetes	0.000659	0.00151	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—LEP—gestational diabetes	0.000656	0.00151	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—LEPR—gestational diabetes	0.00065	0.00149	CbGpPWpGaD
Loperamide—CALM1—Downstream signal transduction—FGF2—gestational diabetes	0.000647	0.00148	CbGpPWpGaD
Loperamide—CALM2—Downstream signal transduction—FGF2—gestational diabetes	0.000647	0.00148	CbGpPWpGaD
Loperamide—CALM2—Signaling by FGFR—FGF2—gestational diabetes	0.000644	0.00148	CbGpPWpGaD
Loperamide—CALM1—Signaling by FGFR—FGF2—gestational diabetes	0.000644	0.00148	CbGpPWpGaD
Loperamide—CALM1—Signaling by ERBB2—FGF2—gestational diabetes	0.00064	0.00147	CbGpPWpGaD
Loperamide—CALM2—Signaling by ERBB2—FGF2—gestational diabetes	0.00064	0.00147	CbGpPWpGaD
Loperamide—CALM2—DAP12 signaling—FGF2—gestational diabetes	0.000637	0.00146	CbGpPWpGaD
Loperamide—CALM1—DAP12 signaling—FGF2—gestational diabetes	0.000637	0.00146	CbGpPWpGaD
Loperamide—CALM3—Signaling by FGFR in disease—FGF2—gestational diabetes	0.00062	0.00142	CbGpPWpGaD
Loperamide—CALM3—Fc epsilon receptor (FCERI) signaling—FGF2—gestational diabetes	0.00062	0.00142	CbGpPWpGaD
Loperamide—CALM3—DAP12 interactions—FGF2—gestational diabetes	0.00062	0.00142	CbGpPWpGaD
Loperamide—CALM3—Signaling by EGFR—FGF2—gestational diabetes	0.000614	0.00141	CbGpPWpGaD
Loperamide—CALM3—Signaling by EGFR in Cancer—FGF2—gestational diabetes	0.000609	0.0014	CbGpPWpGaD
Loperamide—CALM3—Signaling by PDGF—FGF2—gestational diabetes	0.000606	0.00139	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—GGCT—gestational diabetes	0.000603	0.00138	CbGpPWpGaD
Loperamide—CALM1—Signaling by FGFR in disease—FGF2—gestational diabetes	0.0006	0.00138	CbGpPWpGaD
Loperamide—CALM2—DAP12 interactions—FGF2—gestational diabetes	0.0006	0.00138	CbGpPWpGaD
Loperamide—CALM2—Fc epsilon receptor (FCERI) signaling—FGF2—gestational diabetes	0.0006	0.00138	CbGpPWpGaD
Loperamide—CALM1—Fc epsilon receptor (FCERI) signaling—FGF2—gestational diabetes	0.0006	0.00138	CbGpPWpGaD
Loperamide—CALM1—DAP12 interactions—FGF2—gestational diabetes	0.0006	0.00138	CbGpPWpGaD
Loperamide—CALM2—Signaling by FGFR in disease—FGF2—gestational diabetes	0.0006	0.00138	CbGpPWpGaD
Loperamide—CALM1—Signaling by EGFR—FGF2—gestational diabetes	0.000594	0.00136	CbGpPWpGaD
Loperamide—CALM2—Signaling by EGFR—FGF2—gestational diabetes	0.000594	0.00136	CbGpPWpGaD
Loperamide—CALM1—Signaling by EGFR in Cancer—FGF2—gestational diabetes	0.000589	0.00135	CbGpPWpGaD
Loperamide—CALM2—Signaling by EGFR in Cancer—FGF2—gestational diabetes	0.000589	0.00135	CbGpPWpGaD
Loperamide—CALM3—Metabolism—GGCT—gestational diabetes	0.000586	0.00135	CbGpPWpGaD
Loperamide—CALM2—Signaling by PDGF—FGF2—gestational diabetes	0.000586	0.00135	CbGpPWpGaD
Loperamide—CALM1—Signaling by PDGF—FGF2—gestational diabetes	0.000586	0.00135	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—MTNR1B—gestational diabetes	0.000586	0.00134	CbGpPWpGaD
Loperamide—CALM3—B Cell Activation—FGF2—gestational diabetes	0.000574	0.00132	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—RBP4—gestational diabetes	0.000571	0.00131	CbGpPWpGaD
Loperamide—CALM2—Metabolism—GGCT—gestational diabetes	0.000567	0.0013	CbGpPWpGaD
Loperamide—CALM1—Metabolism—GGCT—gestational diabetes	0.000567	0.0013	CbGpPWpGaD
Loperamide—CYP3A4—Biological oxidations—CYP19A1—gestational diabetes	0.000557	0.00128	CbGpPWpGaD
Loperamide—CALM2—B Cell Activation—FGF2—gestational diabetes	0.000555	0.00127	CbGpPWpGaD
Loperamide—CALM1—B Cell Activation—FGF2—gestational diabetes	0.000555	0.00127	CbGpPWpGaD
Loperamide—CYP3A4—Metapathway biotransformation—CYP19A1—gestational diabetes	0.00055	0.00126	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—LEPR—gestational diabetes	0.000549	0.00126	CbGpPWpGaD
Loperamide—CALM3—NGF signalling via TRKA from the plasma membrane—FGF2—gestational diabetes	0.000549	0.00126	CbGpPWpGaD
Loperamide—ABCB1—Allograft Rejection—TNF—gestational diabetes	0.000545	0.00125	CbGpPWpGaD
Loperamide—CALM2—NGF signalling via TRKA from the plasma membrane—FGF2—gestational diabetes	0.000531	0.00122	CbGpPWpGaD
Loperamide—CALM1—NGF signalling via TRKA from the plasma membrane—FGF2—gestational diabetes	0.000531	0.00122	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—GLS2—gestational diabetes	0.000527	0.00121	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—MTNR1B—gestational diabetes	0.000514	0.00118	CbGpPWpGaD
Loperamide—CALM3—Metabolism—GLS2—gestational diabetes	0.000513	0.00118	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—GGCT—gestational diabetes	0.00051	0.00117	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—RBP4—gestational diabetes	0.000501	0.00115	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—FGF2—gestational diabetes	0.000498	0.00114	CbGpPWpGaD
Loperamide—CALM2—Metabolism—GLS2—gestational diabetes	0.000496	0.00114	CbGpPWpGaD
Loperamide—CALM1—Metabolism—GLS2—gestational diabetes	0.000496	0.00114	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—MTNR1B—gestational diabetes	0.000455	0.00104	CbGpPWpGaD
Loperamide—ABCB1—Transmembrane transport of small molecules—GCK—gestational diabetes	0.000452	0.00104	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—GLS2—gestational diabetes	0.000446	0.00102	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—GGCT—gestational diabetes	0.000444	0.00102	CbGpPWpGaD
Loperamide—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	0.000442	0.00101	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—MTNR1B—gestational diabetes	0.00044	0.00101	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—MTNR1B—gestational diabetes	0.00044	0.00101	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—MTNR1B—gestational diabetes	0.000434	0.000996	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—RBP4—gestational diabetes	0.000423	0.000971	CbGpPWpGaD
Loperamide—CALM3—Signaling by NGF—FGF2—gestational diabetes	0.000422	0.000969	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—GGCT—gestational diabetes	0.000419	0.000961	CbGpPWpGaD
Loperamide—CALM2—Signaling by NGF—FGF2—gestational diabetes	0.000408	0.000937	CbGpPWpGaD
Loperamide—CALM1—Signaling by NGF—FGF2—gestational diabetes	0.000408	0.000937	CbGpPWpGaD
Loperamide—CALM3—Immune System—MBL2—gestational diabetes	0.000402	0.000922	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	0.000399	0.000915	CbGpPWpGaD
Loperamide—CALM2—Immune System—MBL2—gestational diabetes	0.000389	0.000892	CbGpPWpGaD
Loperamide—CALM1—Immune System—MBL2—gestational diabetes	0.000389	0.000892	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—GLS2—gestational diabetes	0.000388	0.000892	CbGpPWpGaD
Loperamide—CALM3—Disease—RBP4—gestational diabetes	0.000374	0.000858	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—GLS2—gestational diabetes	0.000366	0.00084	CbGpPWpGaD
Loperamide—CALM2—Disease—RBP4—gestational diabetes	0.000362	0.00083	CbGpPWpGaD
Loperamide—CALM1—Disease—RBP4—gestational diabetes	0.000362	0.00083	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—LEPR—gestational diabetes	0.00034	0.00078	CbGpPWpGaD
Loperamide—CALM3—Disease—NAMPT—gestational diabetes	0.000335	0.00077	CbGpPWpGaD
Loperamide—CALM3—Disease—GCK—gestational diabetes	0.000333	0.000765	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—LEPR—gestational diabetes	0.000329	0.000755	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—LEPR—gestational diabetes	0.000329	0.000755	CbGpPWpGaD
Loperamide—CALM1—Disease—NAMPT—gestational diabetes	0.000324	0.000745	CbGpPWpGaD
Loperamide—CALM2—Disease—NAMPT—gestational diabetes	0.000324	0.000745	CbGpPWpGaD
Loperamide—CALM2—Disease—GCK—gestational diabetes	0.000322	0.00074	CbGpPWpGaD
Loperamide—CALM1—Disease—GCK—gestational diabetes	0.000322	0.00074	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—NAMPT—gestational diabetes	0.000289	0.000662	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—GCK—gestational diabetes	0.000287	0.000658	CbGpPWpGaD
Loperamide—CALM3—Metabolism—NAMPT—gestational diabetes	0.000281	0.000645	CbGpPWpGaD
Loperamide—CALM3—Metabolism—GCK—gestational diabetes	0.000279	0.000641	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—GGCT—gestational diabetes	0.000274	0.000629	CbGpPWpGaD
Loperamide—CALM1—Metabolism—NAMPT—gestational diabetes	0.000272	0.000624	CbGpPWpGaD
Loperamide—CALM2—Metabolism—NAMPT—gestational diabetes	0.000272	0.000624	CbGpPWpGaD
Loperamide—CALM1—Metabolism—GCK—gestational diabetes	0.00027	0.00062	CbGpPWpGaD
Loperamide—CALM2—Metabolism—GCK—gestational diabetes	0.00027	0.00062	CbGpPWpGaD
Loperamide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	0.000269	0.000618	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—MTNR1B—gestational diabetes	0.000269	0.000617	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—RBP4—gestational diabetes	0.000262	0.000601	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—LEP—gestational diabetes	0.00026	0.000597	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—MTNR1B—gestational diabetes	0.00026	0.000597	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—MTNR1B—gestational diabetes	0.00026	0.000597	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—RBP4—gestational diabetes	0.000253	0.000581	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—RBP4—gestational diabetes	0.000253	0.000581	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—NAMPT—gestational diabetes	0.000244	0.000561	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—GCK—gestational diabetes	0.000243	0.000557	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—FGF2—gestational diabetes	0.000241	0.000553	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—GLS2—gestational diabetes	0.000239	0.000549	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—FGF2—gestational diabetes	0.000233	0.000535	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—FGF2—gestational diabetes	0.000233	0.000535	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—FGF2—gestational diabetes	0.000231	0.000531	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—LEP—gestational diabetes	0.000228	0.000524	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—FGF2—gestational diabetes	0.000224	0.000513	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—FGF2—gestational diabetes	0.000224	0.000513	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—NAMPT—gestational diabetes	0.000213	0.000489	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—GCK—gestational diabetes	0.000212	0.000485	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—CYP19A1—gestational diabetes	0.00021	0.000481	CbGpPWpGaD
Loperamide—CALM3—Metabolism—CYP19A1—gestational diabetes	0.000204	0.000468	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—NAMPT—gestational diabetes	0.000201	0.00046	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—GCK—gestational diabetes	0.000199	0.000458	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—FGF2—gestational diabetes	0.000198	0.000454	CbGpPWpGaD
Loperamide—CALM2—Metabolism—CYP19A1—gestational diabetes	0.000197	0.000453	CbGpPWpGaD
Loperamide—CALM1—Metabolism—CYP19A1—gestational diabetes	0.000197	0.000453	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—LEP—gestational diabetes	0.000193	0.000443	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—CYP19A1—gestational diabetes	0.000178	0.000407	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—FGF2—gestational diabetes	0.000173	0.000398	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—CYP19A1—gestational diabetes	0.000155	0.000355	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—FGF2—gestational diabetes	0.000146	0.000336	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—CYP19A1—gestational diabetes	0.000146	0.000335	CbGpPWpGaD
Loperamide—CALM3—Immune System—FGF2—gestational diabetes	0.00014	0.000322	CbGpPWpGaD
Loperamide—CALM1—Immune System—FGF2—gestational diabetes	0.000136	0.000311	CbGpPWpGaD
Loperamide—CALM2—Immune System—FGF2—gestational diabetes	0.000136	0.000311	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—NAMPT—gestational diabetes	0.000131	0.000301	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—GCK—gestational diabetes	0.00013	0.000299	CbGpPWpGaD
Loperamide—CALM3—Disease—FGF2—gestational diabetes	0.000129	0.000297	CbGpPWpGaD
Loperamide—CALM2—Disease—FGF2—gestational diabetes	0.000125	0.000288	CbGpPWpGaD
Loperamide—CALM1—Disease—FGF2—gestational diabetes	0.000125	0.000288	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—LEP—gestational diabetes	0.000119	0.000274	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—LEP—gestational diabetes	0.000115	0.000265	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—LEP—gestational diabetes	0.000115	0.000265	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—CYP19A1—gestational diabetes	9.53e-05	0.000219	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—FGF2—gestational diabetes	9.07e-05	0.000208	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—FGF2—gestational diabetes	8.77e-05	0.000201	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—FGF2—gestational diabetes	8.77e-05	0.000201	CbGpPWpGaD
